Heart specialists at the McGill University Health Centre are the first in the world to implant a minimally-invasive cardiac support system called the Impella 5.0 into a patient who was suffering from acute rejection after a heart transplant. The procedure was performed in the heart catheterization lab by Dr. Renzo Cecere, Director of the MUHC Mechanical Heart Program, and Dr. Jean Phillipe Pelletier, an MUHC Interventional Cardiologist, on February 19.
"In the worldwide experience of about 300 implants of the Impella 5.0, this is the first case of its use in a heart transplant patient suffering from severe acute rejection,” states Dr. Cecere. “This device allowed us to stabilize the patient's condition until she responded to the powerful anti-rejection medications. Without this new technology, this patient would likely not have survived."
Already available in the US and Europe, the Impella 5.0 is most often used as a bridge to a more permanent therapy, allowing doctors more time to develop a definitive treatment strategy. It is designed to help restore cardiac stability in patients who develop heart failure after heart surgery and who have not responded to standard medical therapy. In this case however, the device was implanted in transplant patient where the main purpose was to take the pressure off the patient’s heart in order to allow it time to heal from the trauma of an acute rejection.
The Impella 5.0 is made up of a miniature pump which is mounted in a catheter and inserted through a small incision in the patient’s groin area. The catheter is advanced from the groin to the left ventricle of the heart, where it can stay for up to ten days.
"The Impella system is the most recent acquisition of the MUHC Mechanical Heart Program, and further expands our ability to offer state-of-the-art treatments to patients with advanced heart disease," says Dr. Cecere. Health Canada accepted the technology for use in this country in June, 2007.About the McGill University Health Centre (MUHC)
Rebecca Burns | MUHC
Virtual Reality in Medicine: New Opportunities for Diagnostics and Surgical Planning
07.12.2016 | Universität Basel
3-D printed kidney phantoms aid nuclear medicine dosing calibration
06.12.2016 | Society of Nuclear Medicine
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
08.12.2016 | Life Sciences
08.12.2016 | Physics and Astronomy
08.12.2016 | Materials Sciences